Clinical Edge TNF inhibitors vs abatacept or tocilizumab: Risk for osteoporotic fractures in RA patients Osteoporosis: Can zoledronate prevent bone loss in patients discontinuing denosumab? Idiopathic inflammatory myopathies linked to increased osteoporosis risk Studies eyes risks for poor outcomes in primary sclerosing cholangitis More
